Oracef en es it fr

Oracef Brand names, Oracef Analogs

Oracef Brand Names Mixture

  • None

Oracef Chemical_Formula


Oracef RX_link


Oracef fda sheet

Oracef msds (material safety sheet)

Oracef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Oracef Molecular Weight

363.389 g/mol

Oracef Melting Point


Oracef H2O Solubility

1110 mg/L

Oracef State


Oracef LogP


Oracef Dosage Forms

Capsule; Tablet; Oral liquid

Oracef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Oracef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Oracef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Oracef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Oracef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Oracef Organisms Affected

Enteric bacteria and other eubacteria